Trump signs order to accelerate Ibogaine research for veterans with PTSD

The order focuses on advancing studies of ibogaine, a Schedule I psychedelic drug, for use in treating PTSD, traumatic brain injury, depression, anxiety, suicidal ideatiation, and opiod addiction.

Go to News Site